Reference | Adequate randomisation? | Allocation concealment? | Blinding? Patients? | Blinding? Caregiver? | Blinding? Outcome assessors? | Incomplete outcome data addressed? Dropouts? | Incomplete outcome data? ITT analysis? | Free of suggestions of selective outcome reporting? | Similarity of baseline characteristics? | Cointerventions avoided or similar? | Compliance acceptable in all groups? | Timing of the outcome assessment similar? | Maximum score | Score study | Per cent |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Giombini et al17 | + | + | − | − | + | + | + | + | ? | + | + | + | 12 | 9 | 75 |
Johansson et al18 | + | ? | − | − | + | + | + | + | + | + | + | + | 12 | 9 | 75 |
Aktas et al19 | + | + | + | − | + | + | − | + | + | ? | ? | + | 12 | 8 | 67 |
Dickens et al20 | + | ? | − | − | + | + | + | + | ? | + | ? | + | 12 | 7 | 58 |
Lombardi et al21 | + | ? | − | − | + | + | + | + | ? | − | ? | + | 12 | 6 | 50 |
Senbursa et al22 | ? | ? | − | − | − | + | + | + | + | ? | + | + | 12 | 6 | 50 |
Walther et al23 | ? | ? | − | − | ? | + | ? | + | + | + | ? | + | 12 | 5 | 42 |
Werner et al24 | ? | ? | − | − | ? | + | + | + | − | ? | + | + | 12 | 5 | 42 |
Sauders25 | + | ? | ? | − | + | ? | ? | + | + | ? | ? | + | 12 | 5 | 42 |
Cheng and Hung26 | ? | ? | − | − | ? | + | − | + | + | ? | ? | + | 12 | 4 | 33 |
Methodological quality scores of Green et al16* | |||||||||||||||
Random allocation? | Concealed allocation? | Blind participants? | Blind therapists? | Blind assessors? | Adequate follow-up? | Between-group comparisons? | Intention-to-treat analysis? | Baseline comparability? | Specification of eligibility criteria? | Availability of point estimates and measures of variability of primary outcome measures? | Score maximum | Score study | Per cent | ||
Nykanen27 | + | − | + | + | + | + | + | − | + | + | + | 11 | 9 | 82 | |
Saunders28 | + | ? | + | + | + | − | + | + | + | + | + | 11 | 9 | 82 | |
Vecchio et al29 | + | − | + | + | + | + | + | − | + | + | + | 11 | 9 | 82 | |
Berry et al30 | + | − | − | − | + | + | + | − | + | + | + | 11 | 7 | 64 | |
Conroy and Hayes31 | + | − | − | − | + | + | + | − | + | + | + | 11 | 7 | 64 | |
Dal Conte et al32 | + | − | + | + | − | + | + | − | + | + | − | 11 | 7 | 64 | |
Bang and Deyle et al33 | + | − | − | − | − | + | + | − | + | + | + | 11 | 6 | 55 | |
Brox et al34 | + | − | − | − | + | − | + | + | + | − | + | 11 | 6 | 55 | |
Perron and Malouin35 | + | − | − | − | + | + | + | − | + | − | + | 11 | 6 | 55 | |
Methodological quality scores of Green et al 200515† | |||||||||||||||
Random allocation? | Concealed allocation? | Blind subjects? | Blind therapists? | Blind assessors? | Adequate follow−up? | Between-group comparisons? | Intention-to-treat analysis? | Baseline comparability? | Specification of eligibility criteria? | Availability of point estimates and measures of variability of primary outcome measures? | Score maximum | Score study | Per cent | ||
Berry30 | + | − | − | n.p. | + | + | + | − | + | + | + | 10 | 7 | 70 |
*Based on the PEDro scale (specifically designed and validated for the assessment of validity for trials of physiotherapy interventions) http://ptwww.cchs.usyd.edu.au/pedro/.
†Based on the Cochrane Reviewer's Handbook (Alderson et al36).
+, Yes; −, no; ?, unclear/unsure.
ITT, intention-to-treat.